GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
-8.21%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$222M
AUM Growth
+$222M
Cap. Flow
+$16.7M
Cap. Flow %
7.51%
Top 10 Hldgs %
57.18%
Holding
48
New
9
Increased
13
Reduced
8
Closed
11

Top Buys

1
ELGX
Endologix Inc
ELGX
$8.27M
2
AUPH icon
Aurinia Pharmaceuticals
AUPH
$7.92M
3
EXEL icon
Exelixis
EXEL
$7.8M
4
OCRX
Ocera Therapeutics, Inc.
OCRX
$7.66M
5
VCEL icon
Vericel Corp
VCEL
$6.18M

Top Sells

1
THOR
THORATEC CORPORATION
THOR
$9.03M
2
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
$6.99M
3
ARCT icon
Arcturus Therapeutics
ARCT
$5.76M
4
NBIX icon
Neurocrine Biosciences
NBIX
$5.49M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$4.26M

Sector Composition

1 Healthcare 74.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CCXI
26
DELISTED
ChemoCentryx, Inc.
CCXI
$2.18M 0.94%
+483,741
New +$2.18M
WGBS
27
DELISTED
WaferGen Bio-systems, Inc.
WGBS
$1.83M 0.79%
+421,509
New +$1.83M
TRAW icon
28
Traws Pharma
TRAW
$11.4M
$1.49M 0.64%
345,824
+236,375
+216% +$991K
MEIP icon
29
MEI Pharma
MEIP
$149M
$1.09M 0.47%
157,661
– –
AMRN
30
Amarin Corp
AMRN
$311M
$1.01M 0.43%
+923,534
New +$1.01M
STRM
31
DELISTED
Streamline Health Solutions
STRM
$702K 0.3%
151,611
– –
THOR
32
DELISTED
THORATEC CORPORATION
THOR
$596K 0.26%
22,300
-337,700
-94% -$9.03M
TVRD
33
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
$397K 0.17%
47,321
-152,898
-76% -$1.28M
LRMR icon
34
Larimar Therapeutics
LRMR
$337M
$331K 0.14%
+16,855
New +$331K
AVNR
35
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
– –
-450,000
Closed -$2.54M
VOLC
36
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-232,645
Closed -$4.1M
AVEO
37
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-2,325,000
Closed -$4.26M
PLXP
38
DELISTED
PLx Pharma Inc. Common Stock
PLXP
– –
-124,125
Closed -$1.2M
SCTL
39
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
– –
-520,776
Closed -$4.17M
VIRX
40
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
0
– –
PLX icon
41
Protalix BioTherapeutics
PLX
$128M
– –
-167,787
Closed -$612K
NUWE icon
42
Nuwellis
NUWE
$4.44M
– –
0
-424,208
-100% -$2.38M
KPTI icon
43
Karyopharm Therapeutics
KPTI
$61.4M
– –
-75,000
Closed -$3.49M
INO icon
44
Inovio Pharmaceuticals
INO
$144M
– –
0
– –
EXAS icon
45
Exact Sciences
EXAS
$9.33B
– –
0
– –
ARCT icon
46
Arcturus Therapeutics
ARCT
$467M
– –
-332,908
Closed -$5.76M
KBIO
47
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
– –
-910,699
Closed -$2.08M
EYPT icon
48
EyePoint Pharmaceuticals
EYPT
$827M
– –
-379,060
Closed -$1.65M
1
2